Glaxo, J&J and Myriad move lower in weaker sector
July 09, 2010 at 10:43 AM EDT
Pharmaceutical and biotech benchmarks retreat in early action, undercut by weakness in shares of GlaxoSmithKline, Johnson & Johnson and Myriad Genetics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.